| 1. Altered microRNA profiles of testicular biopsies from patients with nonobstructive azoospermia |
Page:100—105 |
| 2. The association of stromal antigen 3 (STAG3) sequence variations with spermatogenic impairment in the male Korean population |
Page:106—111 |
| 3. Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord |
Page:112—117 |
| 4. Biomedical engineering and erectile restoration: Design considerations for urologic prosthetics |
Page:15—19 |
| 5. Fundamentals of prosthetic urology |
Page:20—27 |
| 6. Updates in penile prosthesis infections |
Page:28—33 |
| 7. Epidemiology regarding penile prosthetic surgery |
Page:2—7 |
| 8. Pain management strategies in penile implantation |
Page:34—38 |
| 9. Penile prosthesis implant in the special populations: Diabetics, neurogenic conditions, fibrotic cases, concurrent urinary continence surgery, and salvage implants |
Page:39—44 |
| 10. Artificial urinary sphincter surgery in the special populations: Neurological, revision, concurrent penile prosthesis and female stress urinary incontinence groups |
Page:45—50 |
| 11. Modern treatment strategies for penile prosthetics in Peyronie's disease: A contemporary clinical review |
Page:51—59 |
| 12. The modern testicular prosthesis: Patient selection and counseling, surgical technique, and outcomes |
Page:64—69 |
| 13. Future considerations in prosthetic urology |
Page:70—75 |
| 14. The role of tyrosine phosphatase Shp2 in spermatogonial differentiation and spermatocyte meiosis |
Page:79—87 |
| 15. Reduced semen quality in patients with testicular cancer seminoma is associated with alterations in the expression of sperm proteins |
Page:88—93 |
| 16. Risk profiling in patients undergoing penile prosthesis implantation |
Page:8—14 |
| 17. Consecutive nightly measurements are needed for accurate evaluation of nocturnal erectile capacity when the first-night laboratory recording is abnormal |
Page:94—99 |
| 18. Reduced semen quality in patients with testicular cancer seminoma is associated with alterations in the expression of sperm proteins. |
Page:88—93 |
| 19. The association of stromal antigen 3 (STAG3) sequence variations with spermatogenic impairment in the male Korean population. |
Page:106—111 |
| 20. Effect of ketotifen fumarate on experimental autoimmune orchitis and torsion of the spermatic cord. |
Page:112—117 |
| 21. Altered microRNA profiles of testicular biopsies from patients with nonobstructive azoospermia. |
Page:100—105 |
| 22. Consecutive nightly measurements are needed for accurate evaluation of nocturnal erectile capacity when the first-night laboratory recording is abnormal. |
Page:94—99 |
| 23. Updating semen analysis: a subpopulation approach. |
Page:118—119 |
| 24. The role of tyrosine phosphatase Shp2 in spermatogonial differentiation and spermatocyte meiosis. |
Page:79—87 |
| 25. Subinguinal microsurgical varicocelectomy is safe and effective in a solitary testicle. |
Page:120—121 |
| 26. Darolutamide: a novel androgen-signaling agent in nonmetastatic castration-resistant prostate cancer. |
Page:76—78 |
| 27. Teasing apart the multiple roles of Shp2 (Ptpn11) in spermatogenesis. |
Page:122—122 |
| 28. Modern treatment strategies for penile prosthetics in Peyronie's disease: a contemporary clinical review. |
Page:51—59 |
| 29. Pain management strategies in penile implantation. |
Page:34—38 |
| 30. Updates in penile prosthesis infections. |
Page:28—33 |
| 31. Risk profiling in patients undergoing penile prosthesis implantation. |
Page:8—14 |
| 32. Prosthetic urology: past, present, and future. |
Page:1—1 |
| 33. Future considerations in prosthetic urology. |
Page:70—75 |
| 34. Fundamentals of prosthetic urology. |
Page:20—27 |
| 35. Biomedical engineering and erectile restoration: design considerations for urologic prosthetics. |
Page:15—19 |
| 36. Management of urethral atrophy after implantation of artificial urinary sphincter: what are the weaknesses? |
Page:60—63 |
| 37. The modern testicular prosthesis: patient selection and counseling, surgical technique, and outcomes. |
Page:64—69 |
| 38. Epidemiology regarding penile prosthetic surgery. |
Page:2—7 |
| 39. Artificial urinary sphincter surgery in the special populations: neurological, revision, concurrent penile prosthesis and female stress urinary incontinence groups. |
Page:45—50 |
| 40. Penile prosthesis implant in the special populations: diabetics, neurogenic conditions, fibrotic cases, concurrent urinary continence surgery, and salvage implants. |
Page:39—44 |
